Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 30, 2016. The report serves as a notification regarding the publication of the 2016 Notice of Annual General Meeting (AGM) and the 2015 Annual Summary.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice rather than a financial results report.
Material Changes
No material financial changes versus prior periods are disclosed in this filing. The document focuses on corporate governance events rather than operational or financial performance shifts.
Guidance, Outlook, and Management Commentary
- Annual General Meeting: Scheduled for Thursday, May 5, 2016, at 2:30 pm at The Queen Elizabeth II Conference Centre in London.
- Document Availability: The 2016 AGM Notice and 2015 Annual Summary are available on the company website and will be submitted to the UK Listing Authority for inspection.
- Shareholder Communications: Paper copies of the AGM Notice and 2015 Annual Report are being sent to shareholders who have elected to receive physical communications.
Investor Verification Checklist
- Verify the date and location of the Annual General Meeting (May 5, 2016, London).
- Access the 2015 Annual Summary and 2016 AGM Notice via the company website or the UK Listing Authority portal.
- Confirm receipt of paper communications if elected as a shareholder.